NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Leukemia. - 31, 1 (2017) , 237-240, ISSN: 0887-6924
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2019
- Creator
-
Byrgazov, Konstantin
Kastner, Renate
Gorna, M.
Hoermann, Gregor
Koenig, Margit
Lucini, Chantal Blanche
Ulreich, Raphael
Benesch, Martin
Strenger, Volker
Lackner, Helmut K.
Schwinger, Wolfgang
Sovinz, Petra
Haas, Oskar Arthur
Heuvel-Eibrink, Marry M. van den
Niemeyer, Charlotte
Hantschel, Oliver
Valent, Peter
Superti-Furga, Giulio
Urban, Christian Ernst
Dworzak, Michael
Lion, Thomas
- DOI
-
10.1038/leu.2016.250
- URN
-
urn:nbn:de:bsz:25-freidok-1337626
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:43 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Byrgazov, Konstantin
- Kastner, Renate
- Gorna, M.
- Hoermann, Gregor
- Koenig, Margit
- Lucini, Chantal Blanche
- Ulreich, Raphael
- Benesch, Martin
- Strenger, Volker
- Lackner, Helmut K.
- Schwinger, Wolfgang
- Sovinz, Petra
- Haas, Oskar Arthur
- Heuvel-Eibrink, Marry M. van den
- Niemeyer, Charlotte
- Hantschel, Oliver
- Valent, Peter
- Superti-Furga, Giulio
- Urban, Christian Ernst
- Dworzak, Michael
- Lion, Thomas
- Klinik für Pädiatrische Hämatologie und Onkologie. Freiburg im Breisgau
- Universität
Time of origin
- 2019
Other Objects (12)
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Investigation of resistance mechanisms in acute myeloid leukaemia towards tyrosine kinase inhibitors with mass spectrometry
Gab2 and its role in Tyrosine Kinase Inhibitor Resistance in chronic myeloid leukemia
Analysis of the impact of Bruton Tyrosine Kinase on Myeloid Cell Development and Function
Axitinib and Sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Hypercalcemia of malignancy : with 17 tables
Editorial: Targeting bruton tyrosine kinase
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia
The expression in eukaryotes of a tyrosine kinase which is reactive with pp60v-src antibodies
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers
An inducible tyrosine kinase receptor for axonal regeneration
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Investigation of resistance mechanisms in acute myeloid leukaemia towards tyrosine kinase inhibitors with mass spectrometry
Gab2 and its role in Tyrosine Kinase Inhibitor Resistance in chronic myeloid leukemia
Analysis of the impact of Bruton Tyrosine Kinase on Myeloid Cell Development and Function
Axitinib and Sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Hypercalcemia of malignancy : with 17 tables
Editorial: Targeting bruton tyrosine kinase
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia
The expression in eukaryotes of a tyrosine kinase which is reactive with pp60v-src antibodies
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers
An inducible tyrosine kinase receptor for axonal regeneration
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Investigation of resistance mechanisms in acute myeloid leukaemia towards tyrosine kinase inhibitors with mass spectrometry
Gab2 and its role in Tyrosine Kinase Inhibitor Resistance in chronic myeloid leukemia
Analysis of the impact of Bruton Tyrosine Kinase on Myeloid Cell Development and Function
Axitinib and Sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Hypercalcemia of malignancy : with 17 tables
Editorial: Targeting bruton tyrosine kinase
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia
The expression in eukaryotes of a tyrosine kinase which is reactive with pp60v-src antibodies
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers